GoodNewsoftheDay

True, recent, well-sourced good news, every morning.

HealthLarge human trial1 min read

New weight-loss drug halves knee pain in trials

Two major clinical trials show a new weight-loss drug significantly reduces knee pain for patients with osteoarthritis.

Researchers led by Northwestern University studied over one thousand participants receiving high doses of the experimental injectable medication retatrutide. People taking this treatment lost an average of roughly a quarter of their total mass during the study period.

When findings from both trials were combined, approximately two-thirds of participants reported a decrease in knee discomfort of at least half the original level. Only 38% of those receiving a placebo experienced that specific level of relief from their joint discomfort.

Benefits extended beyond weight loss as participants showed decreases in blood pressure, cholesterol levels, and systemic inflammation throughout their entire bodies. These improvements suggest the drug addresses multiple health issues simultaneously rather than focusing solely on mass reduction.

Findings from both studies were published on November eighth in the New England Journal of Medicine for medical professionals worldwide. Corresponding author Dr. Thomas Schnitzer said losing significant weight with this treatment offers a good chance for meaningful pain reduction.

“Many of the people in this study lost considerable amounts of weight, with a few losing up to a hundred pounds or more.”

Dr. Thomas Schnitzer

More health news

HealthLarge human trial1 min read

New pill offers hope for pancreatic cancer patients

A new drug called daraxonrasib has shown promise in reducing tumour size for people with advanced pancreatic cancer during a recent medical trial.

· via The Guardian: Science